
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.79 | 0.79 | 0.00 |
Shares | 90.22 | 90.22 | 0.00 |
Convertible | 0.15 | 0.15 | 0.00 |
Other | 8.83 | 8.83 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.62 | 18.78 |
Price to Book | 4.46 | 4.27 |
Price to Sales | 1.83 | 2.28 |
Price to Cash Flow | 18.86 | 15.66 |
Dividend Yield | 0.79 | 1.17 |
5 Years Earnings Growth | 11.10 | 11.17 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.91 | 99.59 |
Financial Services | 0.09 | 0.73 |
Number of long holdings: 142
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.71 | 789.80 | +2.34% | |
Aggregate Miscellaneous Equity | - | 8.83 | - | - | |
UnitedHealth | US91324P1021 | 7.31 | 292.49 | +0.27% | |
Intuitive Surgical | US46120E6023 | 4.92 | 512.64 | +0.08% | |
Stryker | US8636671013 | 4.45 | 390.87 | +0.07% | |
Thermo Fisher Scientific | US8835561023 | 3.94 | 416.31 | -0.40% | |
argenx ADR | US04016X1019 | 3.54 | 577.92 | +3.95% | |
Vertex | US92532F1003 | 3.27 | 469.55 | +1.15% | |
Boston Scientific | US1011371077 | 3.13 | 103.19 | -0.28% | |
Danaher | US2358511028 | 3.07 | 193.30 | +0.23% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 36.35B | 6.33 | 13.53 | 10.82 | ||
T. Rowe Price Blue Chip Growth | 32.66B | 7.80 | 26.86 | 15.03 | ||
T. Rowe Price Capital AppreciationI | 31B | 6.41 | 13.67 | - | ||
T. Rowe Price Blue Chip Growth I | 30.25B | 7.88 | 27.02 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.44B | 7.46 | 25.89 | 16.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review